India News | Press Trust of India | Tuesday April 13, 2021
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
www.ndtv.com